Increased assessment of HER2 in metastatic gastroesophageal cancer patients: a nationwide population-based cohort study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1436-3305
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Increased assessment of HER2 in metastatic gastroesophageal cancer patients: a nationwide population-based cohort study ; day:11 ; month:1 ; year:2020 ; pages:1-12
Gastric cancer ; (11.1.2020), 1-12
- Creator
-
Dijksterhuis, Willemieke P. M.
Verhoeven, Rob H. A.
Meijer, Sybren L.
Slingerland, Marije
Haj Mohammad, Nadia
de Vos-Geelen, Judith
Beerepoot, Laurens V.
van Voorthuizen, Theo
Creemers, Geert-Jan
van Oijen, Martijn G. H.
van Laarhoven, Hanneke W. M.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10120-020-01039-7
- URN
-
urn:nbn:de:101:1-2020041812260413517725
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Dijksterhuis, Willemieke P. M.
- Verhoeven, Rob H. A.
- Meijer, Sybren L.
- Slingerland, Marije
- Haj Mohammad, Nadia
- de Vos-Geelen, Judith
- Beerepoot, Laurens V.
- van Voorthuizen, Theo
- Creemers, Geert-Jan
- van Oijen, Martijn G. H.
- van Laarhoven, Hanneke W. M.
- SpringerLink (Online service)
Other Objects (12)
HER2-targeted advanced metastatic gastric/gastroesophageal junction adenocarcinoma: treatment landscape and future perspectives
Association between gastroesophageal reflux disease and tinnitus in a nationwide population-based cohort study
Progress and challenges in HER2-positive gastroesophageal adenocarcinoma
HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer
Pharmacokinetic and exposure–response analysis of pertuzumab in patients with HER2-positive metastatic gastric or gastroesophageal junction cancer
Circulating tumor DNA predicts outcome in metastatic gastroesophageal cancer
Development of prognostic models for HER2-positive metastatic breast cancer in females: a retrospective population-based study
Risk factors for gastroesophageal reflux disease: a population-based study
Targeted therapies for ER+/HER2- metastatic breast cancer
How We Treat HER2-Positive Metastatic Breast Cancer
Second-line treatment of HER2-positive advanced gastroesophageal adenocarcinoma : Past, present and future
PD-L1 and HER2 Expression in Gastroesophageal Cancer: a Matched Case Control Study
HER2-targeted advanced metastatic gastric/gastroesophageal junction adenocarcinoma: treatment landscape and future perspectives
Association between gastroesophageal reflux disease and tinnitus in a nationwide population-based cohort study
Progress and challenges in HER2-positive gastroesophageal adenocarcinoma
HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer
Pharmacokinetic and exposure–response analysis of pertuzumab in patients with HER2-positive metastatic gastric or gastroesophageal junction cancer
Circulating tumor DNA predicts outcome in metastatic gastroesophageal cancer
Development of prognostic models for HER2-positive metastatic breast cancer in females: a retrospective population-based study
Risk factors for gastroesophageal reflux disease: a population-based study
Targeted therapies for ER+/HER2- metastatic breast cancer
How We Treat HER2-Positive Metastatic Breast Cancer
Second-line treatment of HER2-positive advanced gastroesophageal adenocarcinoma : Past, present and future
PD-L1 and HER2 Expression in Gastroesophageal Cancer: a Matched Case Control Study
HER2-targeted advanced metastatic gastric/gastroesophageal junction adenocarcinoma: treatment landscape and future perspectives
Association between gastroesophageal reflux disease and tinnitus in a nationwide population-based cohort study
Progress and challenges in HER2-positive gastroesophageal adenocarcinoma
HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer
Pharmacokinetic and exposure–response analysis of pertuzumab in patients with HER2-positive metastatic gastric or gastroesophageal junction cancer
Circulating tumor DNA predicts outcome in metastatic gastroesophageal cancer
Development of prognostic models for HER2-positive metastatic breast cancer in females: a retrospective population-based study
Risk factors for gastroesophageal reflux disease: a population-based study
Targeted therapies for ER+/HER2- metastatic breast cancer
How We Treat HER2-Positive Metastatic Breast Cancer
Second-line treatment of HER2-positive advanced gastroesophageal adenocarcinoma : Past, present and future